References

Metazoan MicroRNAs

10.1016/j.cell.2018.03.006 · 2018 · External reference

Relationship between micro RNA expression levels and histopathological features of dysplasia in oral leukoplakia

10.1111/jop.12112 · 2014 · External reference

Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma

10.1093/hmg/ddp446 · 2009 · External reference

MicroRNA-21: An emerging player in bone diseases

2021 · External reference

Salivary miRNAs Expression in Potentially Malignant Disorders of the Oral Mucosa and Oral Squamous Cell Carcinoma: A Pilot Study on miR-21, miR-27b, and miR-181b

10.3390/cancers15010291 · 2023 · External reference

MicroRNA-21 Expression as a Prognostic Biomarker in Oral Cancer: Systematic Review and Meta-Analysis

10.3390/ijerph19063396 · 2022 · External reference

The Biology of Bone Metastasis

10.1101/cshperspect.a031252 · 2018 · External reference

PTENp1, a natural sponge of miR-21, mediates PTEN expression to inhibit the proliferation of oral squamous cell carcinoma

10.1002/mc.22594 · 2017 · External reference

miR-21 promotes osseointegration and mineralization through enhancing both osteogenic and osteoclastic expression

2020 · External reference

LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response

10.3390/ijms25158264 · 2024 · External reference

Nanomaterials for Therapeutic RNA Delivery

10.1016/j.matt.2020.09.020 · 2020 · External reference

MiR-21 Expression in the Tumor Stroma of Oral Squamous Cell Carcinoma: An Independent Biomarker of Disease Free Survival

10.1371/journal.pone.0095193 · 2014 · External reference

MicroRNA-21 as a Regulator of Cancer Stem Cell Properties in Oral Cancer

10.3390/cells14020091 · 2025 · External reference

Keratinization-associated miR-7 and miR-21 Regulate Tumor Suppressor Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) in Oral Cancer

10.1074/jbc.m112.366518 · 2012 · External reference

Zoledronic acid exacerbates inflammation through M1 macrophage polarization

10.1186/s41232-018-0074-9 · 2018 · External reference

MicroRNA-21 Promotes Oral Cancer Invasion via the Wnt/β-Catenin Pathway by Targeting DKK2

10.1007/s12253-013-9689-y · 2014 · External reference

Regulation and function of miRNA-21 in health and disease

10.4161/rna.8.5.16154 · 2011 · External reference

MicroRNAs in Cancer

10.1146/annurev.pathol.4.110807.092222 · 2009 · External reference

Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype

10.1158/0008-5472.can-15-1625 · 2016 · External reference

MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1/5/8-Runx2 pathway

10.1016/j.bbrc.2017.09.119 · 2017 · External reference

Localized therapeutic strategy based on microRNA-21-loaded mesoporous silica nanoparticles hydrogel improves bone repair in medication-related osteonecrosis of the jaw

10.1186/s13018-025-06503-7 · 2025 · External reference

miR-21 promotes the fibrotic properties in oral mucosa through targeting PDCD4

10.1016/j.jds.2021.09.004 · 2022 · External reference

Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients

10.18632/oncotarget.27616 · 2020 · External reference

Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma

10.1093/abbs/gmx078 · 2017 · External reference

Association of salivary miRNAs with onset and progression of oral potentially malignant disorders: Searching for noninvasive biomarkers

10.1016/j.jds.2022.08.002 · 2023 · External reference

MiR-21-5p regulates extracellular matrix degradation and angiogenesis in TMJOA by targeting Spry1

10.1186/s13075-020-2145-y · 2020 · External reference

Circulating miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma: Circulating miR-21

10.12669/pjms.35.5.331 · 2019 · External reference

MicroRNA-21-5p profile in the alveolar bone following tooth extraction in medication-related osteonecrosis of the jaw rat model

10.3389/fdmed.2024.1477274 · 2024 · External reference

Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw

10.1007/s00277-018-3296-7 · 2018 · External reference

MicroRNAs and Bone Regeneration

10.2174/1389202916666150817213630 · 2015 · External reference

Non-coding RNAs in disease: From mechanisms to therapeutics

10.1038/s41576-023-00662-1 · 2024 · External reference

Expression of Salivary miRNA 21 in Oral Submucous Fibrosis (OSMF): An Observational Study

10.2174/2211536609666200127143749 · 2021 · External reference

Programmed cell death 4 loss increases tumor cell invasion and is regulated by miR-21 in oral squamous cell carcinoma

10.1186/1476-4598-9-238 · 2010 · External reference

From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer

10.3390/cells11182791 · 2022 · External reference

Expression Analysis of Circulating microRNAs in Saliva and Plasma for the Identification of Clinically Relevant Biomarkers for Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders

10.3390/cancers16172990 · 2024 · External reference

American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update

10.1016/j.joms.2022.02.008 · 2022 · External reference

MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases

10.1038/nrd.2016.246 · 2017 · External reference

miRNA-21, an oncomiR that regulates cell proliferation, migration, invasion and therapy response in lung cancer

10.1016/j.prp.2024.155601 · 2024 · External reference

Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma

2018 · External reference

The Role of miR-21 in Osteoblasts–Osteoclasts Coupling In Vitro

10.3390/cells9020479 · 2020 · External reference

The Role and Mechanism of MicroRNA 21 in Osteogenesis: An Update

10.3390/ijms241411330 · 2023 · External reference

Regulation of microRNA biogenesis and its crosstalk with other cellular pathways

10.1038/s41580-018-0059-1 · 2019 · External reference

Expression profile of salivary micro RNA-21 and 31 in oral potentially malignant disorders

10.1590/1807-3107bor-2020.vol34.0002 · 2020 · External reference

Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: A brief review

10.1186/s12885-020-07568-9 · 2020 · External reference

miR-21 inhibitor sensitizes human OSCC cells to cisplatin

10.1007/s11033-011-1350-9 · 2012 · External reference

The Role of microRNA in the Regulation of Differentiation and the Functionality of Osteoblasts, Osteoclasts, and Their Precursors in Osteoporosis

10.3390/ncrna11010014 · 2025 · External reference

Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation

10.1016/j.jfma.2020.10.019 · 2021 · External reference

Circulating microRNA Panel as a Novel Biomarker to Diagnose Bisphosphonate-Related Osteonecrosis of the Jaw

10.7150/ijms.27593 · 2018 · External reference

Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis

10.1007/s12105-024-01627-4 · 2024 · External reference

Salivary microRNAs in oral cancer

10.1111/odi.12340 · 2015 · External reference

The role of the immune response in the development of medication-related osteonecrosis of the jaw

2021 · External reference

Inhibition of miR‑21 promotes cell apoptosis in oral squamous cell carcinoma by upregulating PTEN

2018 · External reference

WP1066 Sensitizes Oral Squamous Cell Carcinoma Cells to Cisplatin by Targeting STAT3/miR-21 axis

10.1038/srep07461 · 2014 · External reference